Corporate GovernanceMay 22, 2026, 04:23 PM
NeoGenomics Stockholders Approve 5M Share Increase to Equity Plan
AI Summary
NeoGenomics, Inc. held its Annual Meeting on May 21, 2026, where stockholders approved an amendment to the 2023 Equity Incentive Plan, increasing authorized shares by 5,000,000. All nine director nominees were elected, and the compensation of Named Executive Officers received advisory approval. Additionally, Deloitte & Touche LLP was ratified as the independent registered public accountant.
Key Highlights
- Stockholders approved a 5,000,000 share increase to the 2023 Equity Incentive Plan.
- The Equity Incentive Plan amendment passed with 97.90% of votes cast (108,010,493 For).
- Nine directors were elected to the Board, including Lynn A. Tetrault and Dr. Marjorie C. Green.
- Named Executive Officer compensation received advisory approval with 83.19% of votes cast.
- Deloitte & Touche LLP was ratified as independent auditor with 99.57% of votes cast.
- Approximately 89.61% of outstanding voting stock was represented at the Annual Meeting.
Price Impact
More from NEO